ALNY vs HBNC · P/E 76, rev $1.29B vs P/E 16, rev $175.2M
Alnylam Pharmaceuticals Inc (ALNY) versus Horizon Bancorp (HBNC) — a side-by-side from cached financials, not a winner call.
Alnylam Pharmaceuticals Inc (ALNY) is a biotechnology company listed on US.
Horizon Bancorp (HBNC) is a banks - regional company listed on US.
Latest reported ALNY revenue for 2026-06-30 was $1.29B. Net income was $164.5M. Revenue was up 3.4% from 2025-09-30 to 2026-06-30. ALNY currently screens at market cap $40.46B and trailing P/E 76.3.
Latest reported HBNC revenue for 2026-06-30 was $175.2M. Net income was $51.1M. HBNC currently screens at market cap $709.1M and trailing P/E 15.8.
ALNY currently screens at market cap $40.46B and trailing P/E 76.3. HBNC currently screens at market cap $709.1M and trailing P/E 15.8.
Not investment advice. Open the ALNY and HBNC stock pages for the full models.
Not investment advice.